|
- Antimicrobial resistance
Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death
- General guidance on hold‑time studi
1 Introduction and background Manufacturers should ensure that the products that they manufacture are safe, efective and of the quality required for their intended use Systems should be in place to ensure that pharmaceutical products are produced according to validated processes and to defined procedures Manufacturing processes should be shown to be capable of consistently manufacturing
- Anatomical Therapeutic Chemical (ATC) Classification
In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties Drugs are classified in groups at five different levels
- World Health Organization (WHO)
The United Nations agency working to promote health, keep the world safe and serve the vulnerable
- Defined Daily Dose (DDD) - World Health Organization (WHO)
Drug consumption can be expressed in cost, number of units, number of prescriptions or by the physical quantity of drugs However these variables can vary between regions and countries over time This limits comparisons of drug consumption at an international level To address this, a technical unit of measurement, the Defined Daily Dose (DDD) was created
- Antimicrobial Resistance - World Health Organization (WHO)
As a result of drug resistance, antibiotics and other antimicrobial medicines become inefective and infections become increasingly diicult or impossible to treat
- WHO Drug Information
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
- Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain
|
|
|